Israeli team says new test takes uncertainty out of prostate cancer screening

0
1172
Scientists at the Kaplan Medical Center in Rehovot say they are a step closer to developing a better method to screen for prostate cancer, marking a significant leap forward in removing guesswork from the process. Prostate cancer is the second most common cancer among men around the world, but the main method of testing, screening for increased levels of prostate-specific antigens (PSA) in the blood, remains controversial. Get The Start-Up Israel's Daily Start-Up by email and never miss our top stories FREE SIGN UP Studies have shown that elevated PSA levels can sometimes show up years before a cancer develops or in benign conditions, leading to unnecessary biopsies and anxiety. “There are still questions about whether the benefits of screening outweigh the risks for most men,” the American Cancer Society says on its website. However, Micromedic Technologies says its an initial test of its Celldetect technology managed to detect or rule out cancer in urine samples more accurately than the PSA test. Relying on a clinical study with 59 urine samples at Kaplan, which has been working with CellDetect for the last two years in developing the screening product, the company arrived at a high sensitivity rate of 91.3 percent, meaning it could rule out cancer accurately in most patients. The company also reported a 75% specificity rate, meaning it could detect cancer in three-quarters of people who had it. “The currently available diagnostic testing is known to be unreliable,” said Micromedic CEO, Guy Lerner. “With these clinical study results, we have the potential to transform prostate cancer diagnostics, offering patients a non-invasive, accurate and reliable test, and one that could improve the healthcare system through considerable cost savings.” Tests of CellDetect have previously proven similarly high efficacy rates for detecting cervical and bladder cancer, though the product has yet to receive approval from the US Food and Drug Administration. READ MORE: Startup Israel Prostate cancer Micromedic Kaplan Medical Center cancer Cancer detection 93 shares SPONSORED CONTENT New Vision Discovery Is Leaving Optometrists Baffled (Watch Now) New Vision Discovery Is Leaving Optometrists Baffled (Watch Now) healthnewstips.today Why Doctors Will No Longer Prescribe Blood Pressure Meds Why Doctors Will No Longer Prescribe Blood Pressure Meds healthnewstip This is How She “Get Rid“ Of Toenail Fungus (Watch Now) This is How She “Get Rid“ Of Toenail Fungus (Watch Now) healthnewstips.today The Unusual Link Between Coconut Oil and Alzheimer's The Unusual Link Between Coconut Oil and Alzheimer's healthtipsil Best Antivirus Providers for 2018 - Surprising Providers That Actually Work. Best Antivirus Providers for 2018 - Surprising Providers That Actually Work. My Antivirus Review This Game brings the Elf Fantasy World to Life This Game brings the Elf Fantasy World to Life Elvenar Recommended by SPONSORED STORIES The Chaotic Arab World Has Nothing to Offer Israel (Begin-Sadat Center for Strategic Studies) Russia’s Air Defenses in Syria: More Politics than Punch (Begin-Sadat Center for Strategic Studies) Optometrists Are Surprised: These 3 Foods Shown to Reduce Vision Loss… (healthnewstiptodayil) Surprising New Method to Improve Vision Naturally (Try It Tonight) (healthnewstiptodayil) Films to watch before the 2018 Oscars (From the Grapevine) 'Wonder Woman' is now officially the highest-grossing… (From the Grapevine) FROM THE TIMES OF ISRAEL Letters to the Editor: ‘No proof that we were ever apes’ Billy Graham dies at 99: He championed Israel in public and derided… Gymnast Aly Raisman’s nude photo shoot sends message about surviving… Recommend Israeli Submarine Launched Cruise Missile The Lonely Jew of Faith: Lonely No More Five reasons why Israel is ready for war with Hezbollah in Lebanon Recommended by COMMENTS SPONSORED CONTENT Who designed Meghan Markle's blouse that everyone is talking about? Who designed Meghan Markle's blouse that everyone is talking about? From the Grapevine

CellDetect manages to accurately screen for disease, solving problem of current test which sometimes shows cancer where there is none, makers say

Scientists at the Kaplan Medical Center in Rehovot say they are a step closer to developing a better method to screen for prostate cancer, marking a significant leap forward in removing guesswork from the process.

Prostate cancer is the second most common cancer among men around the world, but the main method of testing, screening for increased levels of prostate-specific antigens (PSA) in the blood, remains controversial.

Studies have shown that elevated PSA levels can sometimes show up years before a cancer develops or in benign conditions, leading to unnecessary biopsies and anxiety.

“There are still questions about whether the benefits of screening outweigh the risks for most men,” the American Cancer Society says on its website.

However, Micromedic Technologies says its an initial test of its Celldetect technology managed to detect or rule out cancer in urine samples more accurately than the PSA test.

Relying on a clinical study with  59 urine samples at Kaplan, which has been working with CellDetect for the last two years in developing the screening product, the company arrived at a high sensitivity rate of 91.3 percent, meaning it could rule out cancer accurately in most patients.

The company also reported a 75% specificity rate, meaning it could detect cancer in three-quarters of people who had it.

“The currently available diagnostic testing is known to be unreliable,” said Micromedic CEO, Guy Lerner. “With these clinical study results, we have the potential to transform prostate cancer diagnostics, offering patients a non-invasive, accurate and reliable test, and one that could improve the healthcare system through considerable cost savings.”

Tests of CellDetect have previously proven similarly high efficacy rates for detecting cervical and bladder cancer, though the product has yet to receive approval from the US Food and Drug Administration.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Questo sito usa Akismet per ridurre lo spam. Scopri come i tuoi dati vengono elaborati.